MedPath

Hepatic insulin resistance and Dopaminergic dysfunction in a Ultra High Risk (UHR) population for Schizophrenia

Conditions
delusion
psychosis
10018424
10039628
Registration Number
NL-OMON31345
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Age 18-35
Ultra high risk symptoms for development of psychosis as defined by McGorry et al (2002).
Healthy controls matched for age, sex, BMI, IQ, ethnicity, viceral and subcutanious fat mass.

Exclusion Criteria

Previous psychotic episode
Previous use of antipsychotics, or regular use of cocaine or amphetamins
Type I and II diabetes mellitus
Renal insufficiency
Family history for type II diabetes mellitus.
Familial dyslipidemia
Treatment with drugs which are known to interfere with glucose or lipid metabolism
Alcohol consumption in excess of 3 units per day or in the last 3 days before the clamp

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Glucose productions (suppression)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>n.a.</p><br>
© Copyright 2025. All Rights Reserved by MedPath